In-silico Identification of Novel Drug Target for Osteoarthritisinhuman using System Network Biology Approaches

25 June 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Osteoarthritis (OA) is the most common form of joint disability in the world affecting a large number of persons s yet the mechanisms responsible for the disease is not well n understood. And therefore there is a lack of disease-modifying treatment options. It has several risk factors from systemic (e.g. age, sex, genetics, obesity) to biochemical factors (e.g. joint injury, muscle weakness, sport). The prevalence of OA is ever increasing due to the obesity epidemic and longevity. Since OA has strong genetic predisposition, in the study we attempted system network biology approach to identify a key candidate gene in a protein-protein interaction (PPI) network of OA, which may play an important role in disease pathogenesis and help us to understand the development and progression of the disease. This information will help in target specific development of new molecules which may eventually lead to curative solutions for OA in human.

Keywords

Osteoarthritis
Joint disability
Genetic predisposition
System network biology
protein-protein interaction networks STRING PPI data

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.